Disease Markers

Disease Markers / 2012 / Article

Open Access

Volume 32 |Article ID 693864 | https://doi.org/10.3233/DMA-2011-0869

Bruna Lancia Zampieri, Joice Matos Biselli, Eny Maria Goloni-Bertollo, Hélio Vannucchi, Valdemir Melechco Carvalho, José Antônio Cordeiro, Érika Cristina Pavarino, "Maternal Risk for Down Syndrome Is Modulated by Genes Involved in Folate Metabolism", Disease Markers, vol. 32, Article ID 693864, 9 pages, 2012. https://doi.org/10.3233/DMA-2011-0869

Maternal Risk for Down Syndrome Is Modulated by Genes Involved in Folate Metabolism

Received23 Feb 2012
Accepted23 Feb 2012


Studies have shown that the maternal risk for Down syndrome (DS) may be modulated by alterations in folate metabolism. The aim of this study was to evaluate the influence of 12 genetic polymorphisms involved in folate metabolism on maternal risk for DS. In addition, we evaluated the impact of these polymorphisms on serum folate and plasma methylmalonic acid (MMA, an indicator of vitamin B12 status) concentrations. The polymorphisms transcobalamin II (TCN2) c.776C>G, betaine-homocysteine S-methyltransferase (BHMT) c.742A>G, methylenetetrahydrofolate reductase (NAD(P)H) (MTHFR) c.677 C>T and the MTHFR 677C-1298A-1317T haplotype modulate DS risk. The polymorphisms MTHFR c.677C>T and solute carrier family 19 (folate transporter), member 1 (SLC19A1) c.80 A>G modulate folate concentrations, whereas the 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR) c.66A>G polymorphism affects the MMA concentration. These results are consistent with the modulation of the maternal risk for DS by these polymorphisms.

Copyright © 2012 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Order printed copiesOrder